IBSS Biomed

Executive Summary

IBSS Biomed is a Polish biotechnology company founded in 2006, based in Warsaw, with a focus on producing biological medicines, specialized probiotics, rehydration preparations, and in vitro diagnostic products. The company leverages extensive practical experience in molecular biology, immunology, and cell cultures to develop and manufacture these products for healthcare markets. As a private entity, IBSS Biomed has established a stable operational base in Poland, serving both domestic and potentially European customers. Its diversified product portfolio spans biologics, probiotics, and diagnostics, positioning it as a versatile player in the biotech sector. While the company lacks recent public catalysts or disclosed pipeline details, its long-standing presence and manufacturing capabilities suggest a steady business model with potential for growth through product line expansions or strategic partnerships.

Upcoming Catalysts (preview)

• Q3 2026Launch of new probiotic product for gastrointestinal health70% success
• Q2 2026CE marking for a new in vitro diagnostic kit60% success
• Q4 2026Partnership or contract manufacturing agreement for biological medicines50% success